Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 13, 2024 07:35 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for...
RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals With OnKure
May 13, 2024 10:28 ET
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed merger of Reneo Pharmaceuticals with OnKure in a stock-for-stock transaction.
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
May 13, 2024 07:35 ET
|
Reneo Pharmaceuticals, Inc.; OnKure, Inc
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have...